Prof. Dong Ma is a distinguished professor at Hebei Medical University, China, specializing in medical sciences and healthcare innovations. With a strong academic background, he has made significant contributions to biomedical research, clinical studies, and medical advancements. His work focuses on developing new treatments, improving patient care, and enhancing healthcare methodologies. Prof. Ma’s research is widely cited in prestigious medical journals, influencing global healthcare policies and practices. As a mentor and scholar, he continues to inspire future medical professionals while fostering international research collaborations. His dedication to medical excellence and innovation ensures a lasting impact in the field.
AUTHOR PROFILE
Scopus Profile
🎓 EARLY ACADEMIC PURSUITS:
Prof. Dong Ma embarked on his academic journey with a strong foundation in medical sciences. He pursued his education in China, demonstrating exceptional aptitude in the field of medicine and research. His early academic years were marked by rigorous studies, participation in innovative projects, and a keen interest in medical advancements.
🏛️ PROFESSIONAL ENDEAVORS:
Prof. Ma is currently a distinguished professor at Hebei Medical University, China. Throughout his career, he has been actively involved in teaching, mentoring, and guiding students in medical sciences. His professional engagements extend beyond the classroom, contributing to the university’s research and global collaborations in medical research and healthcare advancements.
Prof. Ma’s research primarily revolves around medical sciences, healthcare innovations, and clinical applications. His work includes:
- Biomedical Research: Investigating novel treatments and technologies in the medical field.
- Clinical Studies: Conducting evidence-based research to improve patient care and treatment outcomes.
- Medical Innovations: Developing and contributing to new methodologies and technologies in healthcare.
His dedication to research has significantly impacted both theoretical knowledge and practical medical applications, benefiting healthcare professionals and patients alike.
🌍 IMPACT AND INFLUENCE:
Prof. Ma’s contributions have made a profound impact on the medical community. His research has been cited extensively in academic journals, influencing policies and practices in the field of medicine. His work has also led to collaborations with international medical institutions, further amplifying his influence on global healthcare development.
📖 ACADEMIC CITATIONS:
Prof. Ma has been cited in numerous prestigious medical journals and research papers. His publications cover a wide range of topics, including:
- Advances in medical treatments and techniques.
- Healthcare policy improvements.
- Breakthroughs in disease prevention and management.
His academic work serves as a valuable resource for researchers, scholars, and healthcare professionals worldwide.
🏅 LEGACY AND FUTURE CONTRIBUTIONS:
Prof. Dong Ma’s legacy is built upon his relentless pursuit of medical excellence. His future contributions are expected to:
- Drive Innovation: Further enhance medical technologies and treatment approaches.
- Inspire Future Scholars: Mentor upcoming medical professionals and researchers.
- Expand Global Collaborations: Strengthen research ties with international institutions for broader healthcare advancements.
🔥 CONCLUSION:
Prof. Dong Ma stands as a visionary leader in medical sciences, shaping the future of healthcare through groundbreaking research, innovation, and education. His dedication to improving patient care, advancing medical treatments, and mentoring future professionals has left a lasting impact on both academia and clinical practice. With numerous contributions to medical research and extensive collaborations worldwide, he continues to drive progress in healthcare. His legacy is defined by excellence, knowledge, and a passion for medical advancements, ensuring a brighter, healthier future for generations to come.
TOP NOTABLE PUBLICATIONS
The Impact of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio on the Prognosis of Patients with Non-Viral,Non-Alcoholic Hepatocellular Carcinoma:a Retrospective Cohort Study
Authors: Xianzhe Lou, Tongguo Miao, Shiya Zhang, Dong Ma, Yuemin Nan
Journal: Chinese General Practice
Year: 2025
Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma
Authors: Tongguo Miao, Shiya Zhang, Yunjing Zhang, Dong Ma, Yuemin Nan
Journal: Scientific Reports
Year: 2024
Study on the relationship between Methylation of Neuregulin (NRG) Gene and Cervical Carcinoma
Authors: Xizhao Yan, Fenglan An, Zhenzhen Ding, Dong Ma, Xiaohui Yang
Journal: Pakistan Journal of Medical Sciences
Year: 2024
α-HBDH is a superior to LDH in predicting major adverse cardiovascular events in patients with acute aortic dissection
Authors: Yunjing Zhang, Yue Sun, Yongbo Zhao, Dong Ma
Journal: Heliyon
Year: 2024
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease
Authors: Tongguo Miao, Xianzhe Lou, Shiming Dong, Dong Ma, Yuemin Nan
Journal: Journal of Hepatocellular Carcinoma
Year: 2024